A new-generation taxoid SB-T-1214 was evaluated for its efficacy against several drug-resistant human tumor xenografts, including colon tumors (Pgp+ DLD-1) in severe combined immune deficient (SCID) mice in our previous study [49]. This evidence concerns the gene PGP and colonic neoplasm.